RecruitingPhase 2NCT07752979
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
Sponsor: AbbVie
Arlington, VA · Danville, VA · Newport News, VA · +56 more sites
Clinical trials in Arlington, VA
19 recruiting studies have a site in or near Arlington, VA, Virginia.
Top conditions here
- Obesity (6)
- Type 2 Diabetes (4)
- Alzheimer's Disease (3)
- Hypertension (2)
- Lung Cancer (2)
- Heart Failure (2)
- Parkinson's Disease (1)
- Type 1 Diabetes (1)
All conditions
- Alzheimer's Disease
- Asthma
- Breast Cancer
- COPD
- Crohn's Disease
- Depression
- Type 1 Diabetes
- Type 2 Diabetes
- Heart Failure
- Hypertension
- Leukemia
- Lung Cancer
- Lupus
- Migraine
- Multiple Sclerosis
- Obesity
- Parkinson's Disease
- Prostate Cancer
- Psoriasis
- Rheumatoid Arthritis
- Schizophrenia
- Sickle Cell Disease
- Ulcerative Colitis
- Colorectal Cancer
Showing 19 of 19 studies
RecruitingPhase 3NCT05980949
Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of KarXT in Subjects With Psychosis Associated With Alzheimer's Disease (ADEPT-3)
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Arlington, VA · +147 more sites
RecruitingPhase 2 / Phase 3NCT06712316
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer (ROSETTA Lung-02)
Sponsor: BioNTech SE
Arlington, VA · Fairfax, VA · Richmond, VA · +50 more sites
RecruitingPhase 3NCT07177352
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
Sponsor: Hoffmann-La Roche
Arlington, VA · Fairfax, VA · Richmond, VA · +65 more sites
RecruitingPhase 3NCT07181109
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Sponsor: Alnylam Pharmaceuticals
Arlington, VA · Danville, VA · Fairfax, VA · +270 more sites
RecruitingPhase 3NCT07128199
A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection
Sponsor: Taiho Oncology, Inc.
Arlington, VA · Fairfax, VA · Manassas, VA · +27 more sites
RecruitingPhase 3NCT07717411
A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease
Sponsor: Hoffmann-La Roche
Arlington, VA · +11 more sites
RecruitingPhase 3NCT07222800
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Sponsor: Pfizer
Arlington, VA · Blacksburg, VA · Fairfax, VA · +251 more sites
RecruitingPhase 3NCT07684235
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
Sponsor: Amgen
Arlington, VA · Newport News, VA · Winchester, VA · +68 more sites
RecruitingPhase 3NCT07761117
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Sponsor: AstraZeneca
Arlington, VA · +119 more sites
RecruitingPhase 3NCT06742723
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Sponsor: AstraZeneca
Arlington, VA · Manassas, VA · Newport News, VA · +130 more sites
RecruitingPhase 3NCT07339423
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Sponsor: Novo Nordisk A/S
Arlington, VA · Newport News, VA · Winchester, VA · +19 more sites
RecruitingPhase 3NCT07037459
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Sponsor: Amgen
Arlington, VA · Falls Church, VA · Manassas, VA · +118 more sites
RecruitingPhase 2NCT07804615
A Study to Evaluate the Efficacy, PK, Safety, and Tolerability of VIM0423 in Adults With Parkinson's Disease Tremor Insufficiently Responsive to Dopaminergic Therapy
Sponsor: Vima Therapeutics
Arlington, VA · +28 more sites
RecruitingPhase 3NCT07662135
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
Sponsor: AstraZeneca
Arlington, VA · +32 more sites
RecruitingPhase 3NCT07662109
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Arlington, VA · Newport News, VA · +38 more sites
RecruitingPhase 3NCT07784725
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Sponsor: AstraZeneca
Arlington, VA · +32 more sites
Not yet recruitingPhase 3NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Sponsor: Eli Lilly and Company
Arlington, VA · Newport News, VA · +52 more sites
Not yet recruitingPhase 3NCT07881458
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Sponsor: Eli Lilly and Company
Arlington, VA · +24 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.